B. Agan

发表

Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

Helen M. Chun, M. Roediger, K. H. Hullsiek, 2012, The Journal of infectious diseases.

Combining Epidemiologic and Biostatistical Tools to Enhance Variable Selection in HIV Cohort Analyses

Ionut Bebu, Brian K. Agan, Vincent Marconi, 2014, PloS one.

Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience.

B. Gazzard, B. Larder, J. Metcalf, 2011, AIDS patient care and STDs.

CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals

B. Agan, V. Marconi, M. Dolan, 2008, PloS one.

The Influence of CCL 3 L 1 Gene – Containing Segmental Duplications on HIV-1 / AIDS Susceptibility

B. Rovin, M. Bamshad, B. Freedman, 2009 .

CCL 3 L 1-CCR 5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals

B. Agan, V. Marconi, M. Dolan, 2022 .

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

American Journal of Epidemiology Original Contribution the Timing of Hepatitis B Virus (hbv) Immunization Relative to Human Immunodeficiency Virus (hiv) Diagnosis and the Risk of Hbv Infection following Hiv Diagnosis

Helen M. Chun, K. H. Hullsiek, B. Agan, 2022 .

High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction

B. Agan, A. Ganesan, R. Maves, 2021, PloS one.

M. Polansky, B. Agan, G. Macalino, 2018, Health and Quality of Life Outcomes.

Factors associated with 10 years of continuous viral load suppression on HAART

B. Agan, A. Ganesan, J. Okulicz, 2016, BMC Infectious Diseases.

Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?

K. H. Hullsiek, B. Agan, A. Weintrob, 2010, AIDS.

Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.

B. Agan, V. Marconi, M. Dolan, 2008, The Journal of infectious diseases.

Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort

B. Agan, A. Saphire, E. Berger, 2016, AIDS research and human retroviruses.

Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study

B. Agan, A. Ganesan, R. Deiss, 2016, AIDS Research and Therapy.

Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study

B. Agan, A. Ganesan, R. Deiss, 2016, AIDS Research and Therapy.

Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States

B. Agan, A. Esber, R. Maves, 2022, Scientific reports.

Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.

B. Agan, V. Marconi, S. Anderson, 2009, The Journal of infectious diseases.

Refractive surgery in the HIV-Positive U.S. Military Natural History Study Cohort: Complications and risk factors.

G. Legault, B. Agan, R. Maves, 2019, Journal of cataract and refractive surgery.

Effectiveness of highly-active antiretroviral therapy by race/ethnicity

S. Gange, B. Agan, M. Dolan, 2006, AIDS.

Obesity among HIV-Infected Persons: Impact of Weight on CD4 Cell Counts

L. Eberly, M. Roediger, B. Agan, 2009 .

Cutaneous malignancies among HIV-infected persons.

K. H. Hullsiek, B. Agan, A. Weintrob, 2009, Archives of internal medicine.

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort

L. Eberly, B. Agan, A. Ganesan, 2012, AIDS Research and Therapy.

A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS)

C. Rentsch, B. Agan, W. Bradley, 2013, PloS one.

Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19.

B. Agan, A. Ganesan, S. Pollett, 2021, Open forum infectious diseases.

Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection

Rupal M Mody, C. Broder, B. Agan, 2021, Open forum infectious diseases.

Effect of HIV infection and antiretroviral therapy on immune cellular functions.

B. Agan, A. Ganesan, M. Robb, 2019, JCI insight.

MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity

D. Douek, A. Somasunderam, B. Agan, 2016, PLoS pathogens.

Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis

K. Schalper, B. Agan, S. Kaech, 2022, Journal for ImmunoTherapy of Cancer.

Potential use of microarray technology for rapid identification of central nervous system pathogens.

L. Folio, B. Agan, R. Rowley, 2004, Military medicine.

D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events

B. Agan, A. Ganesan, A. Justice, 2016, PloS one.

Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study

Stephen A. Berry, B. Agan, A. Ganesan, 2016, Journal of the International AIDS Society.

Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

D. Richman, S. Little, B. Agan, 2015, JAMA internal medicine.

Hepatitis B Vaccine Responsiveness and Clinical Outcomes in HIV Controllers

B. Agan, A. Ganesan, R. Deiss, 2014, PloS one.

Hepatitis B Vaccine Antibody Response and the Risk of Clinical AIDS or Death

Helen M. Chun, K. H. Hullsiek, B. Agan, 2012, PloS one.

Anal cancers among HIV-infected persons: HAART is not slowing rising incidence

K. H. Hullsiek, B. Agan, A. Weintrob, 2010, AIDS.

Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.

K. H. Hullsiek, B. Agan, S. Peel, 2009, Vaccine.

The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients

M. Roediger, K. H. Hullsiek, B. Agan, 2009, Journal of acquired immune deficiency syndromes.

Review of the U.S. military's human immunodeficiency virus program: a legacy of progress and a future of promise.

B. Agan, S. Peel, N. Michael, 2017, MSMR.

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms

F. Pereyra, T. Miura, B. Walker, 2007, Nature Immunology.

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors' reply.

K. H. Hullsiek, B. Agan, A. Weintrob, 2009, AIDS (London).

Risk Factors Influencing Antibody Responses to Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Antigens in Patients Under Antiretroviral Therapy

Xiu-fen Lei, B. Pollock, B. Agan, 2011, Journal of acquired immune deficiency syndromes.

Age, Race, and At-Risk Drinking in an HIV-infected U.S. Military Cohort.

B. Agan, A. Ganesan, R. Deiss, 2019, Military medicine.

Characterizing the Association Between Alcohol and HIV Virologic Failure in a Military Cohort on Antiretroviral Therapy.

B. Agan, A. Ganesan, I. Bebu, 2016, Alcoholism, clinical and experimental research.

The Intersection of HIV, Diabetes, and Race: Exploring Disparities in Diabetes Care among People Living with HIV

B. Agan, A. Ganesan, Mohammed K. Ali, 2020, Journal of the International Association of Providers of AIDS Care.

The per-protocol effect of immediate vs. deferred ART initiation in the START randomized trial.

S. Cole, H. Chu, M. Hernán, 2016, AIDS.

Unintended smallpox vaccination of HIV-1-infected individuals in the United States military.

M. Wallace, B. Agan, S. Tasker, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy

B. Agan, Kirk A Easley, M. Paiardini, 2020, PloS one.

Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia

B. Agan, W. Bradley, A. Ganesan, 2015, BMC Research Notes.

Statin usage and cardiovascular risk among people living with HIV in the U.S. Military HIV Natural History Study

B. Agan, A. Ganesan, R. Deiss, 2021, HIV medicine.

Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.

B. Agan, A. Ganesan, N. Crum‐Cianflone, 2017, Vaccine.

Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.

Rupal M Mody, C. Broder, B. Agan, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era

B. Agan, A. Ganesan, R. Maves, 2021, Open forum infectious diseases.

Are HIV-positive persons progressing faster after diagnosis over the epidemic?

L. Eberly, B. Agan, A. Weintrob, 2010, Journal of acquired immune deficiency syndromes.

335. Antiretroviral Therapy Anchor-based Trends in Body Mass Index following Treatment Initiation among Military Personnel with HIV

B. Agan, A. Ganesan, T. Sunil, 2019, Military medicine.

CHALLENGES IN MANAGEMENT OF WARFARIN ANTI-COAGULATION IN ADVANCED HIV/AIDS PATIENTS WITH VENOUS THROMBOTIC EVENTS--A CASE SERIES FROM A RESEARCH CLINIC IN RURAL KERICHO, KENYA.

B. Agan, I. Sereti, F. Kirui, 2013, East African medical journal.

HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.

L. Kuller, B. Agan, A. Justice, 2014, Current HIV research.

The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection.

M. Roediger, B. Agan, A. Weintrob, 2010, Vaccine.

Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals

Helen M. Chun, K. H. Hullsiek, B. Agan, 2010, AIDS.

Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019.

Rupal M Mody, B. Agan, A. Ganesan, 2021, Open forum infectious diseases.

Surveillance of transcriptomes in basic military trainees with normal, febrile respiratory illness, and convalescent phenotypes

C. Tibbetts, D. Stenger, B. Agan, 2005, Genes and Immunity.

Association of Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization With High-Risk Sexual Behaviors in Persons Infected With Human Immunodeficiency Virus (HIV)

B. Agan, A. Weintrob, N. Crum‐Cianflone, 2011, Medicine.

Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines

Rupal M Mody, C. Broder, David D. Odineal, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

HIV Care Continuum and Meeting 90-90-90 Targets: Cascade of Care Analyses of a U.S. Military Cohort.

B. Agan, A. Ganesan, A. Anglemyer, 2020, Military medicine.

Laboratory diagnosis of Bartonella infections.

B. Agan, M. Dolan, 2002, Clinics in laboratory medicine.

Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection

Rupal M Mody, C. Broder, B. Agan, 2022, bioRxiv.

Brief Report: Racial Comparison of D-Dimer Levels in US Male Military Personnel Before and After HIV Infection and Viral Suppression

B. Agan, A. Ganesan, R. Tracy, 2018, Journal of acquired immune deficiency syndromes.

Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia

J. Ananworanich, B. Agan, I. Sereti, 2020 .

Hepatitis E Virus Infection in HIV-infected Persons

B. Agan, W. Bradley, A. Weintrob, 2012, Emerging infectious diseases.

Multidrug-Resistant Organisms from Ophthalmic Cultures: Antibiotic Resistance and Visual Acuity.

B. Agan, P. McGann, Capt Alexandra J Schulte, 2020, Military medicine.

Randomized, Double-Blind, Placebo-Controlled Study on Decolonization Procedures for Methicillin-Resistant Staphylococcus aureus (MRSA) among HIV-Infected Adults

B. Agan, A. Weintrob, N. Crum‐Cianflone, 2015, PloS one.

Specific Behaviors Predict Staphylococcus aureus Colonization and Skin and Soft Tissue Infections Among Human Immunodeficiency Virus-Infected Persons

B. Agan, A. Weintrob, N. Crum‐Cianflone, 2015, Open forum infectious diseases.

HIV infection among U.S. Army and Air Force military personnel: sociodemographic and genotyping analysis.

B. Agan, E. Sanders-Buell, F. McCutchan, 2010, AIDS research and human retroviruses.

Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection

R. Koup, B. Agan, R. Paris, 2017, Pathogens & immunity.

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

Rupal M Mody, C. Broder, B. Agan, 2021, bioRxiv.

Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAART

M. Roediger, B. Agan, A. Weintrob, 2008, Journal of acquired immune deficiency syndromes.

Persistent Low-Level Viremia while on Antiretroviral Therapy is an Independent Risk Factor for Virologic Failure.

B. Agan, A. Ganesan, R. Deiss, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Brief Report: Prevalence of Posttreatment Controller Phenotype Is Rare in HIV-Infected Persons After Stopping Antiretroviral Therapy

B. Agan, W. Bradley, A. Ganesan, 2017, Journal of acquired immune deficiency syndromes.

Toxoplasma gondii seroprevalence: 30-year trend in an HIV-infected US military cohort.

B. Agan, W. Bradley, A. Ganesan, 2016, Diagnostic microbiology and infectious disease.

Syphilis co-infection does not affect HIV disease progression

B. Agan, A. Weintrob, G. Wortmann, 2010, International journal of STD & AIDS.

Non-Communicable Diseases: Yet Another Challenge for HIV Treatment and Care in Sub-Saharan Africa.

B. Agan, V. Marconi, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States

B. Agan, A. Ganesan, A. Esber, 2021, Scientific Reports.

Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)‐infected and HIV‐uninfected adults

B. Agan, N. Crum‐Cianflone, J. Maguire, 2012, Clinical and experimental immunology.

A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.

M. Roediger, B. Agan, A. Weintrob, 2010, The Journal of infectious diseases.

Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19

J. Brandsma, B. Agan, J. Dumler, 2022, Scientific Reports.

Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

C. Broder, B. Agan, L. Katzelnick, 2022, Cell Host & Microbe.

Ophthalmic Disease Prevalence and Incidence among People Living with HIV in AFRICOS.

B. Agan, A. Esber, H. Kibuuka, 2020, Ophthalmology.

Progestogen-Only Injectable Hormonal Contraceptive Use Should be Considered in Analysis of Studies Addressing the Loss of Bone Mineral Density in HIV-Positive Women

L. Eberly, B. Agan, A. Weintrob, 2010 .

Role of CCL3L1-CCR5 Genotypes in the Epidemic Spread of HIV-1 and Evaluation of Vaccine Efficacy

B. Agan, V. Marconi, M. Dolan, 2008, PloS one.

HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles

B. Agan, M. Landrum, V. Marconi, 2008, PloS one.

Results of a 25-Year Longitudinal Analysis of the Serologic Incidence of Syphilis in a Cohort of HIV-Infected Patients With Unrestricted Access to Care

B. Agan, A. Ganesan, G. Wortmann, 2012, Sexually transmitted diseases.

Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.

K. H. Hullsiek, B. Agan, W. Bradley, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons

B. Agan, A. Ganesan, R. Deiss, 2015, BMC Infectious Diseases.

Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons: Analysis of the Pre-, Early, and Late HAART (Highly Active Antiretroviral Therapy) Eras

Mark R Wallace, Scott Wegner, M. Wallace, 2006, Journal of acquired immune deficiency syndromes.

The Effect of Human Immunodeficiency Virus on Hepatitis B Virus Serologic Status in Co-Infected Adults

B. Agan, A. Weintrob, A. Ganesan, 2010, PloS one.

HIV Outcomes in Hepatitis B Virus Coinfected Individuals on HAART

C. Thio, B. Agan, W. Bradley, 2014, Journal of acquired immune deficiency syndromes.

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals

D. Richman, S. Little, S. Frost, 2008, Nature Medicine.

Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

M. Wallace, B. Agan, W. Bradley, 2011, The Journal of infectious diseases.

Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons.

L. Eberly, M. Roediger, B. Agan, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Delayed-type hypersensitivity (DTH) test anergy does not impact CD4 reconstitution or normalization of DTH responses during antiretroviral therapy

B. Agan, J. Okulicz, O. Mesner, 2014, Journal of the International AIDS Society.

Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1–Postive Subjects Receiving Antiretroviral Therapy

Michael A. Polis, B. Agan, G. Wortmann, 2011, Journal of acquired immune deficiency syndromes.

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

B. Agan, A. Weintrob, A. Ganesan, 2010, AIDS research and therapy.

Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Edward Wright, Stuart Neil, B. Agan, 2008, Cell host & microbe.

Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic

L. Eberly, M. Roediger, B. Agan, 2010, PloS one.

Incidence and risk factors for the occurrence of non‐AIDS‐defining cancers among human immunodeficiency virus‐infected individuals

M. Wallace, B. Agan, D. Blazes, 2005, Cancer.

Extragenital chlamydia infection among active-duty women in the United States Navy

B. Agan, R. Deiss, G. Macalino, 2019, Military Medical Research.

The US Military HIV Natural History Study: Informing Military HIV Care and Policy for Over 30 Years.

B. Agan, A. Ganesan, M. Robb, 2019, Military medicine.

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

K. H. Hullsiek, B. Agan, A. Weintrob, 2009, AIDS.

Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

B. Agan, A. Weintrob, A. Ganesan, 2009, The Journal of infectious diseases.

Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection

C. Broder, B. Agan, A. Ganesan, 2021, bioRxiv.

Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.

B. Agan, A. Ganesan, N. Crum‐Cianflone, 2016, Vaccine.

Impact of Weight on Immune Cell Counts among HIV-Infected Persons

L. Eberly, M. Roediger, B. Agan, 2011, Clinical and Vaccine Immunology.

Trends and Causes of Hospitalizations Among HIV-Infected Persons During the Late HAART Era: What Is the Impact of CD4 Counts and HAART Use?

B. Agan, A. Weintrob, A. Ganesan, 2010, Journal of acquired immune deficiency syndromes.

Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays.

David A Stenger, Donald Seto, Anthony P Malanoski, 2006, Genome research.

Regimen Switching After Initial Haart By Race in a Military Cohort

B. Agan, A. Ganesan, J. Okulicz, 2017 .

M. Polansky, B. Agan, G. Macalino, 2017, PloS one.

Herpes simplex virus type 2 and HIV infection among US military personnel: implications for health prevention programmes

B. Agan, S. Peel, N. Crum‐Cianflone, 2009, International journal of STD & AIDS.

Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors

Bryan R. Smith, D. Reich, S. Rapoport, 2021, Neurology.

Expanded sexually transmitted infection surveillance efforts in the United States military: a time for action.

K. Holmes, O. Soge, J. Pavlin, 2013, Military medicine.

Gonorrhoea or chlamydia in a US military HIV-positive cohort

B. Agan, A. Weintrob, A. Ganesan, 2012, Sexually Transmitted Infections.

Medical Encounter Characteristics of HIV Seroconverters in the US Army and Air Force, 2000–2004

B. Agan, N. Michael, Jose L. Sanchez, 2011, Journal of acquired immune deficiency syndromes.

The VACS Index Predicts Mortality in a Young, Healthy HIV Population Starting Highly Active Antiretroviral Therapy

B. Agan, A. Weintrob, A. Ganesan, 2014, Journal of acquired immune deficiency syndromes.

Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service.

B. Agan, A. Ganesan, M. Kortepeter, 2013, MSMR.

Elevated CD8 Counts During HAART Are Associated With HIV Virologic Treatment Failure

K. H. Hullsiek, B. Agan, A. Weintrob, 2011, Journal of acquired immune deficiency syndromes.

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity

C. Broder, B. Agan, A. Ganesan, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Biomedical Response to Neisseria gonorrhoeae and Other Sexually Transmitted Infections in the US Military.

B. Agan, A. Jerse, E. Garges, 2019, Military medicine.

The Association between Sexually Transmitted Infections, Length of Service and Other Demographic Factors in the U.S. Military

B. Agan, A. Ganesan, R. Deiss, 2016, PloS one.

A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis.

B. Agan, A. Weintrob, A. Ganesan, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seroprevalence and Seroincidence of Herpes Simplex Virus (2006–2010), Syphilis (2006–2010), and Vaccine-Preventable Human Papillomavirus Subtypes (2000–2010) Among US Military Personnel

B. Agan, A. Ganesan, M. Kortepeter, 2015, Sexually transmitted diseases.

COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment

C. Broder, B. Agan, A. Ganesan, 2021, Open forum infectious diseases.

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression

Jeff E. Mold, Brian K. Agan, Vincent C. Marconi, 2008, Proceedings of the National Academy of Sciences.

Predictors of health-related quality of life among military HIV-infected individuals

M. Polansky, B. Agan, S. Peel, 2020, Quality of Life Research.

Azithromcyin might not protect against Treponema pallidum infection or reactivation in HIV type 1-infected patients.

B. Agan, W. Bradley, N. Crum, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies

C. Broder, B. Agan, L. Katzelnick, 2022, Science Translational Medicine.

Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries

C. Broder, B. Agan, A. Ganesan, 2021, The Journal of infectious diseases.

The epidemiology of herpes simplex virus type 2 infections in a large cohort of HIV-infected patients, 2006-2014.

B. Agan, A. Ganesan, R. Deiss, 2016, MSMR.

Race/ethnicity and HAART initiation in a military HIV infected cohort

M. Roediger, B. Agan, A. Weintrob, 2014, AIDS Research and Therapy.

Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.

B. Agan, A. Weintrob, A. Ganesan, 2015, AIDS research and human retroviruses.

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection

B. Agan, S. Pollett, A. Scher, 2023, JAMA network open.

Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people with HIV and severe lymphopenia.

J. Ananworanich, B. Agan, Jing Wang, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort

L. Eberly, B. Agan, A. Weintrob, 2011, AIDS research and therapy.

Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons

L. Eberly, B. Agan, A. Weintrob, 2013, Neurology.

Effects of human immunodeficiency virus status on symptom severity in influenza-like illness in an otherwise healthy adult outpatient cohort

P. Danaher, B. Agan, A. Ganesan, 2021, Journal of Investigative Medicine.

Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS

Michael A. Polis, B. Agan, A. Ganesan, 2011, PloS one.

Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care

B. Agan, A. Weintrob, A. Ganesan, 2009, Journal of acquired immune deficiency syndromes.

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

B. Gazzard, R. Kaiser, B. Larder, 2021, The Journal of antimicrobial chemotherapy.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Dechao Wang, Shanmugam Saravanan, John Baxter, 2018, The Journal of antimicrobial chemotherapy.

COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health

B. Agan, S. Pollett, D. Tribble, 2022, Open forum infectious diseases.

A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms

B. Agan, S. Pollett, J. Livezey, 2023, PloS one.

Immunologic resilience and COVID-19 survival advantage

Peter B Polk, R. E. Phillips, D. Richman, 2021, Journal of Allergy and Clinical Immunology.

Topological data analysis identifies distinct biomarker phenotypes during the inflammatory phase of COVID-19

J. Brandsma, B. Agan, A. Ganesan, 2021, medRxiv.

An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection

B. Agan, S. Pollett, A. Scher, 2022, Open Forum Infectious Diseases.

CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.

B. Agan, A. Weintrob, A. Ganesan, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Gamaldo and McArthur

B. Agan, N. Crum‐Cianflone, S. Letendre, 2012 .

Prospective Evaluation of an Abbreviated Test Battery to Screen for Neurocognitive Impairment in HIV-Positive Military Members

Bryan R. Smith, B. Agan, A. Ganesan, 2021, AIDS and Behavior.

Identification of an Abbreviated Test Battery for Detection of HIV-Associated Neurocognitive Impairment in an Early-Managed HIV-Infected Cohort

L. Eberly, M. Roediger, B. Agan, 2012, PloS one.

Racial Comparison of D-Dimer Levels in Adults Before and After HIV Infection

B. Agan, A. Ganesan, R. Tracy, 2015 .

Association between depression and HIV treatment outcomes in a US military population with HIV infection

B. Agan, A. Ganesan, T. Sunil, 2020, AIDS Research and Therapy.

Posttraumatic Stress Disorder and Neurocognitive Impairment in a U.S. Military Cohort of Persons Living with HIV

B. Agan, A. Ganesan, N. Crum‐Cianflone, 2019, Psychiatry.

Baseline Albumin/Globulin Ratio Predicted Progression to AIDS Among Persons with Stage 1 HIV Disease in the Pre-Combination Antiretroviral Therapy Era

C. Olsen, B. Agan, A. Ganesan, 2016 .

Relationship between depression and risk behaviors in a US Military population with HIV infection

B. Agan, A. Ganesan, R. Deiss, 2019, AIDS care.

Neurocognitive Dysfunction With Neuronal Injury in People With HIV on Long-Duration Antiretroviral Therapy

Bryan R. Smith, D. Reich, B. Agan, 2023, Neurology.

Reply to Pomara et al. and Valcour et al.: Age and the APOE ε4/ε4 genotype in HIV-1-associated dementia

R. Mahley, B. Agan, J. McCune, 2008, Proceedings of the National Academy of Sciences.

Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia

B. Agan, W. Bradley, A. Ganesan, 2015, BMC Research Notes.

Generalized Confidence Intervals and Fiducial Intervals for Some Epidemiological Measures

T. Mathew, B. Agan, I. Bebu, 2016, International journal of environmental research and public health.

Inference for Surrogate Endpoint Validation in the Binary Case

T. Mathew, B. Agan, I. Bebu, 2015, Journal of biopharmaceutical statistics.

The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

B. Rovin, M. Bamshad, B. Freedman, 2005, Science.

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

B. Agan, A. Weintrob, A. Ganesan, 2010, AIDS Research and Therapy.

HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels

B. Agan, M. Landrum, J. Okulicz, 2015, HIV medicine.

Sexual Risk Behaviors Associated with Sexually Transmitted Infections in a US Military Population Living with HIV After the Repeal of "Don't Ask, Don't Tell".

B. Agan, A. Ganesan, R. Deiss, 2020, AIDS patient care and STDs.

Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.

Scott Wegner, Vincent Marconi, L. Eberly, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

Peter B Polk, D. Richman, A. Anzueto, 2023, Nature communications.

The per-protocol effect of immediate versus deferred antiretroviral therapy initiation

Haitao Chu, Stephen R Cole, Roger Logan, 2016, AIDS.

Sensitivity of the Multispot HIV-1/HIV-2 Rapid Test Using Samples from Human Immunodeficiency Virus Type 1-Positive Individuals with Various Levels of Exposure to Highly Active Antiretroviral Therapy

B. Agan, N. Michael, S. Anderson, 2006, Journal of Clinical Microbiology.

Open Access Research

B. Agan, A. Weintrob, A. Ganesan, 2022 .

A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity

C. Broder, B. Agan, V. Munster, 2020, medRxiv.

The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

B. Rovin, M. Bamshad, B. Freedman, 2005, Science.

HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels

B. Agan, M. Landrum, J. Okulicz, 2015, HIV medicine.

Parametric cost-effectiveness inference with skewed data

Thomas Mathew, George Luta, Paul A. Kennedy, 2016, Comput. Stat. Data Anal..

Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses

C. Broder, D. Esposito, B. Agan, 2021, medRxiv.

Determinants of incident chronic kidney disease and progression in a cohort of HIV‐infected persons with unrestricted access to health care

K. H. Hullsiek, B. Agan, A. Weintrob, 2013, HIV medicine.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Association between quantitative varicella-zoster virus antibody levels and zoster reactivation in HIV-infected persons

B. Agan, A. Ganesan, R. Deiss, 2018, AIDS Research and Therapy.

Characterizing the Association Between Alcohol and HIV Virologic Failure in a Military Cohort on Antiretroviral Therapy.

B. Agan, A. Ganesan, I. Bebu, 2016, Alcoholism, clinical and experimental research.

Reply to Yang et al.

B. Agan, A. Ganesan, O. Mesner, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Level Viremia Is Associated With Serious non-AIDS Events in People With HIV

B. Agan, T. Lalani, R. Colombo, 2024, Open forum infectious diseases.